<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2022-03-31</publicationDate>
    
        <volume>15</volume>
        <issue>1</issue>

 
    <startPage>305</startPage>
    <endPage>312</endPage>

	 
      <doi>10.13005/bpj/2368</doi>
        <publisherRecordId>43405</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Mutation Occurrence in Tor2 Gene in Patients with SARS COV-2 in Aassociation with H. Influenza Infection</title>

    <authors>
	 


      <author>
       <name>Bushra Qasim Dhumad</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Safa Ibrahim Jaber</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">College of health and Medical Technology, Middle Technical University, Baghdad/Iraq</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">SARS COV-2is a very dangerous virus that has led to many deaths. <em>H. Influenza</em>is a bacteria that causes many infections inside the human body, such as pneumonia. In this study, a total of (60)blood samples were taken from patients infected with SARS COV-2shared with<em> H. Influenza</em> infection who attended Ibn-Al-Baladi Hospital/Baghdad city during the period from 15<sup>th</sup> January to 1<sup>st</sup> December 2021. Venous blood samples were also taken from (60) healthy individuals as a control group. The results showed that the distribution rate of the SARS COV-2 IgG and <em>H. influenza</em> IgG among the male patients was twice44 (73.3%)more than the distribution rate among female patients. The prevalence of SARS COV-2 IgG and <em>H. influenza</em> IgG was shown to be the highest among the age group (&gt;51) years, followed by the age group (21-30) years. The cases of SARS COV-2and <em>H. influenza</em> infections among the studied patients according to residency were shown to be almost equal among rural and urban residents 30,30 (49.2%,50.8%) respectively. Regarding the relationship between SARS COV-2 IgG and <em>H. influenza</em> IgG and CRP levels, the mean level of CRP in the patients was (73.72±17.05) and in the the controls was (8.71±1.12), while the mean level of H. influenza IgG in the patients was (1.05±0.23) and in the control group was (0.3±0.02), whereas the mean level of SARS COV-2 IgG was (7.00±2.15) in the patients andwas (0.35 ±0.19) in the controls with a highly significant differences (HS).The number and percentage of patients with positive SARS COV-2 and H. influenza IgG was 38(95.0%) who had high levels of GOT up to 65 U/L, while 2(50%) of those patients had GOT &gt;65 U/L, while the Negative infections with SARS COV-2 IgG, <em>H. influenza</em> IgG 17(85.0%) had up 65 U/L and 3(15.0 %) had&gt;65 U/L level (P =0.03).In addition, high levels of GPT, Alkaline phosphates, urea and creatinine were recorded among patients groups when compared with the healthy controls.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol15no1/mutation-occurrence-in-tor2-gene-in-patients-with-sars-cov-2-in-aassociation-with-h-influenza-infection/</fullTextUrl>

<keywords language="eng">

      
        <keyword>H. Influenza Infection</keyword>
      

      
        <keyword> Mutation</keyword>
      

      
        <keyword> SARS COV-2</keyword>
      

      
        <keyword> Tor2 gene</keyword>
      
</keywords>
  </record>
</records>